Transdermal hormone replacement therapy improves vertebral bone density in primary biliary cirrhosis: results of a 1-year controlled trial

2004 ◽  
Vol 19 (5) ◽  
pp. 563-570 ◽  
Author(s):  
S. P. Pereira ◽  
J. O'Donohue ◽  
C. Moniz ◽  
M. G. Phillips ◽  
H. Abraha ◽  
...  
Keyword(s):  
Hormone Replacement Therapy ◽  
Bone Density ◽  
Primary Biliary Cirrhosis ◽  
Replacement Therapy ◽  
Controlled Trial ◽  
Hormone Replacement ◽  
Biliary Cirrhosis ◽  
Vertebral Bone

Hormone replacement therapy with estradiol and drospirenone: An overview of the clinical data

2006 ◽  
Vol 12 (1_suppl) ◽  
pp. 4-7 ◽  
Author(s):  
Malcolm Whitehead
Keyword(s):  
Hormone Replacement Therapy ◽  
Bone Density ◽  
Replacement Therapy ◽  
Endometrial Hyperplasia ◽  
Hormone Replacement ◽  
Estrogen Therapy ◽  
New Form ◽  
The Uk ◽  
Mineralocorticoid Activity ◽  
Synthetic Progestogen

A new form of continuous combined hormone replacement therapy has become available that contains estradiol and drospirenone as the progestogen component. Drospirenone is a synthetic progestogen, the only one in hormone replacement therapy in the UK that possesses clinically relevant anti-mineralocorticoid activity. The combination of estradiol and drospirenone has been shown to provide relief from estrogen-deficiency symptoms of the menopause. It also helps to prevent osteoporosis in postmenopausal women by increasing bone density. Further, it has been shown to provide protection against endometrial hyperplasia associated with unopposed estrogen therapy.

Effect of Bone Density Information on Decisions About Hormone Replacement Therapy

1997 ◽  
Vol 89 (3) ◽  
pp. 321-325
Author(s):  
STUART L. SILVERMAN ◽  
MARIA GREENWALD ◽  
RAYMOND A. KLEIN ◽  
BARBARA L. DRINKWATER
Keyword(s):  
Hormone Replacement Therapy ◽  
Bone Density ◽  
Replacement Therapy ◽  
Hormone Replacement
Sign in / Sign up

Export Citation Format

Share Document